ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Introducing the Biosimilar Paradigm to Neurology: The Totality of Evidence for the First Biosimilar Natalizumab.

Krzysztof Selmaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.